Feed LH
LH
Laboratory Corporation of America
LH · NYSE
$330.51 +2.58% (+$8.33)
1M +14.87%
Market Cap $26.4B
P/E Ratio 26.36x
Div. Yield 0.89%
ROE 11.57%
Bulios Fair Price
$274.22
17.0% downside
Preț actual
$330.51
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile LH sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Strong
8/9Valuation
54 /100
Fair P/E 26.36x
EV/EBITDA 15.36x
P/S 1.84x
Growth
17 /100
Declining EPS growth 9.17%
Rev. growth 5.55%
FCF growth 6.47%
Profitability
51 /100
Moderate Gross margin 27.85%
Net margin 6.99%
Op. margin 11.27%
Quality
51 /100
Average ROIC 7.93%
ROE 11.57%
ROA 5.41%
Debt
59 /100
Moderate Debt/Equity 0.79x
Current ratio 1.80x
Int. coverage 6.41x
Stability
72 /100
Stable Beta 0.84x
Rev. volatility 2.66%
EPS volatility 75.74%
Întreabă StockBot despre LH
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter
Employees
71,000
Headquarters
Burlington
Evenimente viitoare
28 AUG.
Ex-Dividend
Ex-dividend date
11 SEPT.
Dividend Payment
Data plății
27 OCT.
Earnings
Upcoming earnings report